Role of selective V1a receptor agonism in ovine septic shock

Critical Care Medicine

Volumn 39, Issue 1, 2011, Pages 119-125

  Rehberg, Sebastian ^a   Ertmer, Christian ^a   Vincent, Jean L ^b   Morelli, Andrea ^c   Schneider, Mareike ^a   Lange, Matthias ^a   Van Aken, Hugo ^a   Traber, Daniel L ^c,d   Westphal, Martin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ERASME HOSPITAL   (Belgium)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

multiple organ failure; oxidative stress; peritonitis; sepsis; vascular leakage; vasopressin

Indexed keywords

3 NITROTYROSINE; ARGIPRESSIN; ARGIPRESTOCIN; BASE; CREATININE; HEME OXYGENASE 1; LACTIC ACID; NORADRENALIN; SODIUM CHLORIDE; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE TITRATION; FEMALE; HEART LEFT VENTRICLE WORK; HEART PRELOAD; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; LABORATORY; LUNG GAS EXCHANGE; LUNG PARENCHYMA; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; METABOLIC DISORDER; NONHUMAN; OXYGEN TRANSPORT; PERITONITIS; PRIORITY JOURNAL; SEPTIC SHOCK; SHEEP; URINE VOLUME; ANIMAL; BLOOD GAS ANALYSIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; HEMODYNAMICS; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; OXYGEN CONSUMPTION; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; REFERENCE VALUE; SURVIVAL RATE;

ANIMALS; ARGININE VASOPRESSIN; BLOOD GAS ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; NOREPINEPHRINE; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; RECEPTORS, VASOPRESSIN; REFERENCE VALUES; SHEEP; SHEEP, DOMESTIC; SHOCK, SEPTIC; SURVIVAL RATE; VASOTOCIN;

EID: 78651226079     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fa3898     Document Type: Article

References (35)

1. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
2. Russell J, Walley K, Singer J, et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887
3. Petersen MB: The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease. Basic Clin Pharmacol Toxicol 2006;99: 96-103
4. Barrett LK, Singer M, Clapp LH: Vasopressin: Mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007;35:33-40
5. Kaufmann JE, Lezzi M, Vischer UM: Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling. J Thromb Haemost 2003;1:821-828
6. Traber DL: Selective V1a receptor agonists in experimental septic shock [Abstract]. Crit Care 2007;11(Suppl 4):P51
7. Kanwar S, Woodman RC, Poon MC, et al: Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 1995;86:2760-2766
8. Rehberg S, Laporte R, Enkhbaatar P, et al: Arginine vasopressin increases plasma levels of von Willebrand factor in sheep. Crit Care 2009;13(Suppl):A182
9. Rehberg S, Ertmer C, Kohler G, et al: Role of arginine vasopressin and terlipressin as firstline vasopressor agents in fulminant ovine septic shock. Intensive Care Med 2009;35: 1286-1296
10. Morelli A, Ertmer C, Rehberg S, et al: Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study. Crit Care 2009;13:R130
11. Wang Z, Su F, Rogiers P, et al: Beneficial effects of recombinant human activated protein C in a ewe model of septic shock. Crit Care Med 2007;35:2594-2600
12. Westphal M, Stubbe H, Sielenkamper AW, et al: Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003;31:1502-1508
13. Westphal M, Cox RA, Traber LD, et al: Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vasoconstriction. Crit Care Med 2006;34:1428-1436
14. Westphal M, Enkhbaatar P, Schmalstieg FC, et al: Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep. Crit Care Med 2008;36:1196-1204
15. Dunser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003;107:2313-2319
16. Dunser MW, Mayr AJ, Ulmer H, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001;93:7-13
17. Luckner G, Dunser MW, Jochberger S, et al: Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33:2659-2666
18. Sun Q, Dimopoulos G, Nguyen DN, et al: Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003;168:481-486
19. Torgersen C, Dunser MW, Wenzel V, et al: Comparing two different arginine vasopressin doses in advanced vasodilatory shock: A randomized, controlled, open-label trial. Intensive Care Med 2010;36:57-65
20. Mihara T, Tarumi T, Sugimoto Y, et al: [Arg8]-vasopressin-induced increase in in- tracellular Ca2 concentration in cultured rat hippocampal neurons. Brain Res Bull 1999;49:343-347
21. Berde B, Boissonnas RA, Huguenin RL, et al: Vasopressin analogues with selective pressor activity. Experientia 1964;20:42-43
22. Albanese J, Leone M, Delmas A, et al: Terlipressin or norepinephrine in hyperdynamic septic shock: A prospective, randomized study. Crit Care Med 2005;33:1897-1902
23. Ertmer C, Rehberg S, Westphal M: Vasopressin analogues in the treatment of shock states: Potential pitfalls. Best Pract Res Clin Anaesthesiol 2008;22:393-406
24. Asfar P, Pierrot M, Veal N, et al: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003;31:215-220
25. Asfar P, Hauser B, Ivanyi Z, et al: Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005;33:373-380
26. Laporte R, Wisniewska H, Callejas L, et al: The selective V1a receptor agonist FE 202158 reverses platelet activating factor (PAF)- induced hypotension, vascular leak, impaired tissue perfusion, and mortality in rats. Shock 2008;29(Suppl 1):P21
27. Radi R: Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004;101:4003-4008
28. Chung SW, Liu X, Macias AA, et al: Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 2008;118: 239-247
29. Lange M, Connelly R, Traber DL, et al: Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med 2009;37:223-229
30. Enkhbaatar P, Connelly R, Wang J, et al: Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med 2009;37:208-214
31. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-1210
32. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582
33. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989;256:F274-278
34. Tanoue A: New topics in vasopressin receptors and approach to novel drugs: Effects of vasopressin receptor on regulations of hormone secretion and metabolisms of glucose, fat, and protein. J Pharmacol Sci 2009;109: 50-52
35. Zhao L, Brinton RD: Suppression of proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha in astrocytes by a V1 vasopressin receptor agonist: A cAMP response element-binding protein-dependent mechanism. J Neurosci 2004;24:2226-2235